Safety and effectiveness of favipiravir for novel coronavirus (COVID-19): a rapid review of available evidence
Abstract Introduction: Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared for the first time in December 2019 in Wuhan, China. Due to the lack of unified and integrated evidence for favipiravir, this study was conducted with the ai...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2020-10-01
|
| Series: | Health Technology Assessment in Action |
| Online Access: | https://htainaction.tums.ac.ir/index.php/hta/article/view/27 |